CLOs on the Move


 
Biorez is dedicated to helping patients return to full activity sooner and safer following debilitating ligament and tendon injuries. We have developed the BioBrace™ scaffold, a new implant technology to reinforce tendon and ligament repairs and to facilitate tissue regeneration. Through our proprietary open porous architecture, and use of biomaterials, the BioBrace™ has been engineered to provide a high degree of bio-inductivity to promote rapid tissue regeneration, a biomechanical profile to reinforce repairs throughout the full healing profile, and full absorption overtime to fully restore the anatomy to its normal state. Early pre-clinical work suggests the BioBrace will deliver on ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.biorez.com
  • 470 James Street #14
    New Haven, CT USA 06513
  • Phone: 860.301.8638

Executives

Name Title Contact Details

Similar Companies

independence medical

Since 1990, Independence Medical has been one of the nation's leading wholesale medical supply distributors. Being a privately held company, we are responsive to your ever-changing needs and flexible in developing the best services for your company. You

Ray Foster Dental Supply

Ray Foster Dental Supply is a Huntington Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Prescott's Orthotics and Prosthetics

Prescott's Orthotics & Prosthetics is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

net32.com

net32.com is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MY01

MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.